Natera Inc. (NTRA)
NTRA trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$395.65
-0.53% on the day
Market cap
$57.0B
Large cap
Revenue · 2025
$2.3B
+35.9% on 2024
Net income · 2025
-$208.2M
-9.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NTRA on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001604821 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.3B |
| Net income | -$208.2M |
| Operating income | -$309.9M |
| Net margin | -9.0% |
| Operating margin | -13.4% |
| Revenue growth | +35.9% |
| Cash | Not in SEC XBRL data |
| Total assets | $2.4B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 24.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2025-12-10 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.0% |
| 1 month | +12.8% |
| 3 months | +46.6% |
| Year to date | +72.7% |
| 1 year | +127.1% |
| From 52-week high | -7.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HUM | Humana Inc. | $420.38 | -3.03% | $50.5B |
| CI | The Cigna Group | $282.53 | -0.29% | $74.7B |
| ILMN | Illumina Inc. | $271.18 | -1.99% | $40.9B |
| ELV | Elevance Health Inc. | $425.27 | +0.75% | $92.2B |
| CNC | Centene Corporation | $68.86 | +2.75% | $34.0B |
| DGX | Quest Diagnostics Incorporated | $230.46 | -0.93% | $25.4B |
| LH | Labcorp Holdings Inc. | $313.64 | -0.60% | $25.4B |
| GH | Guardant Health Inc. | $162.09 | -0.43% | $21.8B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier